Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	Sample type	Gender
Reversed Phase NEGATIVE (Named metabolites)	aspartate	155	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	4499	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	4772	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	5119	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	5218	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	5331	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	5440	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	5459	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	5781	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	5978	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	6009	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	6043	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	6064	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	6089	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	6170	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	6263	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	6278	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	6306	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	6323	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	6367	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	6519	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	6542	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	6576	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	6613	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	6617	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	6652	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	6728	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	6739	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	6764	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	6785	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	6800	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	6818	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	6900	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	6901	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	6973	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	6975	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	6986	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	6988	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	7014	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	7058	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	7068	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	7090	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	7144	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	7169	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	7172	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	7213	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	7229	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	7242	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	7258	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	7269	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	7270	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	7321	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	7327	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	7364	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	7408	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	7440	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	7445	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	7448	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	7477	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	7522	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	7612	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	7619	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	7621	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	7645	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	7708	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	7719	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	7745	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	7753	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	7772	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	7774	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	7782	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	7887	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	7906	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	7950	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8016	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8048	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8067	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8125	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8130	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8136	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8163	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8173	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8197	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8230	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8269	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8273	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8312	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8363	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8389	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8412	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8418	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8464	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8471	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8492	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8507	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8548	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8563	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8569	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8578	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8582	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8620	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8639	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8666	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8675	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8706	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8736	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8747	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8773	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8776	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8833	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8882	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8923	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8929	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8963	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8966	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8977	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	8994	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9007	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9014	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9025	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9042	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9053	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9171	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9179	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9193	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9269	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9279	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9292	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9294	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9310	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9331	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9337	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9349	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9357	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9364	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9366	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9368	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9371	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9389	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9403	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9415	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9418	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9451	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9458	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9472	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9474	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9477	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9483	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9490	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9492	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9521	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9545	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9552	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9560	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9564	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9567	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9567	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9571	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9571	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9590	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9599	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9602	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9604	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9631	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9639	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9650	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9651	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9673	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9702	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9702	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9715	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9732	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9746	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9746	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9759	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9788	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9796	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9802	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9805	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9809	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9823	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9826	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9829	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9842	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9865	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9875	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9881	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9895	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9896	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9928	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	9979	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	10043	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	10083	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	10140	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	aspartate	10149	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	10221	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	10244	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	10244	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	aspartate	10248	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	aspartate	10263	Peak area normalized	Sample	male

Return to search page